Global systems unprepared for rising threat of invasive fungal infections
More strategies, both therapeutic and educational, are needed to combat fungal infections that are becoming more widespread.
Comment & Opinion
CPHI 2026: Finding the right CDMO partner in an age of consolidation
Suspected plague outbreak in Russia: public health risk lower than Covid-19
CPHI 2026: Moderna builds on its COVID-era manufacturing lessons
EASD 2026: Tirzepatide outperforms semaglutide in real-world type 2 diabetes analysis
EASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis
EASD 2026: Orforglipron shows an efficacy edge over oral semaglutide in T2D
China expands its manufacturing role for biopharma’s new drugs
